Defining secondary progressive multiple sclerosis

Johannes Lorscheider; Katherine Buzzard; Vilija Jokubaitis; Tim Spelman; Jeannette Lechner-Scott; Pam McCombe; Steve Vucic; Michael Barnett; Helmut Butzkueven; Tomas Kalincik

Conference Proceedings

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Tim Spelman, Jeannette Lechner-Scott, Pam McCombe, Steve Vucic, Michael Barnett, Helmut Butzkueven, Tomas Kalincik

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2015

University of Melbourne Researchers

Timothy Spelman Author Surgery - St Vincent's Hospital

Tomas Kalincik Author Medicine - Royal Melbourne Hospital

Related Projects (4)

Is MS treatment effective long-term?

Multiple Sclerosis is an illness affecting more than 20,000 Australians, and causes significant disability and social disruption in most suf..

CENTRE FOR TRANSLATIONAL NEUROSCIENCE: A MODULAR PLATFORM FOR TRANSLATING DISCOVERY INTO HEALTH OUTCOMES

Clinical Centre of Research Excellence in Translational Neuroscience will provide people, pathways and resources to create a novel platform ..

CENTRE FOR TRANSLATIONAL NEUROSCIENCE: A MODULAR PLATFORM FOR TRANSLATING DISCOVERY INTO HEALTH OUTCOMES

Clinical Centre of Research Excellence in Translational Neuroscience will provide people, pathways and resources to create a novel platform ..

TREATING PROGRESSIVE MULTIPLE SCLEROSIS

While there are numerous therapies for relapsing-remitting multiple sclerosis (MS), therapy for progressive MS remains elusive. This project..

Keywords

Science & Technology

Clinical Neurology

Neurosciences & Neurology

Neurosciences

Life Sciences & Biomedicine

Progressive Multiple Sclerosis Clinical Phenotypes